Loring Wolcott & Coolidge Fiduciary Advisors’s MacroGenics MGNX Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$984	Hold	213	–	–	﹤0.01%	560
2026 Q1	$767	Hold	213	–	–	﹤0.01%	555
2025 Q4	$392	Hold	213	–	–	﹤0.01%	529
2025 Q3	$390	Hold	213	–	–	﹤0.01%	524
2025 Q2	$258	Hold	213	–	–	﹤0.01%	516
2025 Q1	$364	Hold	213	–	–	﹤0.01%	550
2024 Q4	$679	Hold	213	–	–	﹤0.01%	542
2024 Q3	$767	Hold	213	–	–	﹤0.01%	558
2024 Q2	$1.15K	Hold	213	–	–	﹤0.01%	541
2024 Q1	$3.28K	Hold	213	–	–	﹤0.01%	542
2023 Q4	$3.05K	Hold	213	–	–	﹤0.01%	532
2023 Q3	$1.09K	Hold	213	–	–	﹤0.01%	590
2023 Q2	$1.14K	Hold	213	–	–	﹤0.01%	617
2023 Q1	$1.53K	Hold	213	–	–	﹤0.01%	577
2022 Q4	$1.43K	Hold	213	–	–	﹤0.01%	558
2022 Q3	$0	Hold	213	–	–	﹤0.01%	622
2022 Q2	$0	Hold	213	–	–	﹤0.01%	661
2022 Q1	$2K	Hold	213	–	–	﹤0.01%	617
2021 Q4	$3K	Hold	213	–	–	﹤0.01%	679
2021 Q3	$4K	Hold	213	–	–	﹤0.01%	673
2021 Q2	$6K	Buy	+213	New	+$6.24K	﹤0.01%	722
2021 Q1	–	Sell	-213	Closed	-$5K	–	543
2020 Q4	$5K	Hold	213	–	–	﹤0.01%	687
2020 Q3	$5K	Hold	213	–	–	﹤0.01%	547
2020 Q2	$6K	Hold	213	–	–	﹤0.01%	531
2020 Q1	$1K	Hold	213	–	–	﹤0.01%	634
2019 Q4	$2K	Hold	213	–	–	﹤0.01%	650
2019 Q3	$3K	Hold	213	–	–	﹤0.01%	625
2019 Q2	$4K	Hold	213	–	–	﹤0.01%	627
2019 Q1	$4K	Hold	213	–	–	﹤0.01%	606
2018 Q4	$3K	Hold	213	–	–	﹤0.01%	616
2018 Q3	$5K	Hold	213	–	–	﹤0.01%	568
2018 Q2	$4K	Hold	213	–	–	﹤0.01%	590
2018 Q1	$5K	Hold	213	–	–	﹤0.01%	623
2017 Q4	$4K	Hold	213	–	–	﹤0.01%	620
2017 Q3	$4K	Hold	213	–	–	﹤0.01%	608
2017 Q2	$4K	Hold	213	–	–	﹤0.01%	597
2017 Q1	$4K	Hold	213	–	–	﹤0.01%	587
2016 Q4	$4K	Hold	213	–	–	﹤0.01%	573
2016 Q3	$6K	Hold	213	–	–	﹤0.01%	572
2016 Q2	$6K	Buy	+213	New	+$4.8K	﹤0.01%	585

Other funds holding MGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's MGNX Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors held its MacroGenics (MGNX) position steady in Q2 2026 at 213 shares worth $984. The position accounts for ﹤0.01% of the portfolio, ranked #560.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in MGNX in Q2 2016 and has held it in 40 quarters since. The position peaked at $6K in Q2 2021. 49 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Loring Wolcott & Coolidge Fiduciary Advisors held 213 shares of MacroGenics worth $984 as of Q2 2026.
Loring Wolcott & Coolidge Fiduciary Advisors left its MacroGenics share count unchanged in Q2 2026.
MacroGenics made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #560 holding.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in MacroGenics in Q2 2016 and has held it in 40 quarters since.
Loring Wolcott & Coolidge Fiduciary Advisors's MacroGenics position peaked at $6K in Q2 2021.
49 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.